TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Complexa raises $13M to fund trials of kidney disease drug

Email Newsletters

Click here to sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Wednesday, June 4, 2014, 10:51 a.m.
 

Complexa Inc., a South Side-based drug development company, said it raised $13 million from investors that will fund clinical trials of a drug to treat kidney disease.

The funding round, Complexa's second, was led by Jafco Life Science Investment, an arm of Japanese private equity firm Jafco Co. Ltd.

The company previously raised more than $8 million from venture capital investors to license and develop molecules discovered and patented by professor Bruce Freeman and a team of researchers at the University of Pittsburgh.

There is “great interest” in Complexa's work from large pharmaceutical companies, Jafco officials said in a statement.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.

 

 

 


Show commenting policy

Most-Read Business Headlines

  1. Experts: If health insurers’ safeguard goes broke, consumers could pay
  2. Camera prevalence approaches sci-fi realm
  3. Rules could kick door open for nuclear power
  4. Nike, Under Armour invest in watching exercisers’ steps
  5. Visa limits vex businesses
  6. Paper’s prevalence unlikely to diminish
  7. Scented society is killing cheap perfume industry
  8. Kings Family Restaurants sold to California firm
  9. Tech sector drives gains on Wall Street
  10. ‘Promposals’ can be small as burritos, big as Jumbotrons
  11. Mylan raises bid for fellow drugmaker; Perrigo says ‘no’